Contraindicated in patients with a history of any blood dyscrasia or hepatic dysfunction.
- TRADE NAMES: Felbamyl; Felbatol (MedPointe); Taloxa
- INDICATIONS: Partial seizures
- CLASS: Anticonvulsant (see also antiepileptic (anti-seizure))
- HALF-LIFE: 13–23 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Levonorgestrel, Ulipristal
- See adverse reactions attributed to class:
APLASTIC ANEMIA and HEPATIC FAILURE
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 01/11/2024
